Cellectis SA (CLLS)

4.42 +0.15 (+3.51%) USD  |  NASDAQ  |  Apr 17, 16:00
4.37 -0.05 (-1.13%) After-Hours: 20:00
More

Cellectis SG&A Expense (Quarterly) : 4.798M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
DBV Technologies SA 12.79M
EDAP TMS SA 13.22M
Sanofi --
Akari Therapeutics Plc 2.138M
Biodexa Pharmaceuticals Plc --